BioSpace News Archive

Milestone Pharmaceuticals Inc. today reported financial results for the third quarter ended September 30, 2021 and provided a clinical and corporate update.

Plus Therapeutics, Inc. today announced that on November 11, 2021, it granted option awards to Norman LaFrance, M.D.

Verrica Pharmaceuticals Inc. today announced financial results for the third quarter ended September 30, 2021.

Amgen (NASDAQ: AMGN) today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency

NeuPath Health Revenue Growth Remains Strong at 26% in Q3 2021

Vertex Receives CHMP Positive Opinion for KAFTRIO ® (ivacaftor/tezacaftor/elexacaftor) in Combination With Ivacaftor in Children With Cystic Fibrosis Ages 6 Through 11

Prometheus Biosciences, Inc. (Nasdaq: RXDX), today reported financial results for the quarter ended September 30, 2021.

Motus GI Holdings, Inc., a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, reported its financial results for the third quarter and nine months ended September 30, 2021, and provided a corporate update.

MaxCyte, Inc., a leading commercial cell-engineering company focused on providing enabling platform technologies to advance innovative cell-based research as well as next-generation cell therapeutic discovery, development and commercialization, announced Company management will participate in the following investor conferences.

Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), (“Vallon” or the “Company”), a clinical-stage biopharmaceutical company primarily focused on the development of novel drugs that are designed to deter abuse in the treatment of central nervous system (CNS) disorders, today reported its financial results for the quarter ended September 30, 2021.